Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID‐19 in patients with chronic liver disease

BACKGROUND AND AIMS: Cholestasis is associated with disease severity and worse outcome in COVID‐19. Cases of secondary sclerosing cholangitis (SSC) after severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection have been described. APPROACH AND RESULTS: Hospitalized patients with COVID...

Descripción completa

Detalles Bibliográficos
Autores principales: Hartl, Lukas, Haslinger, Katharina, Angerer, Martin, Semmler, Georg, Schneeweiss‐Gleixner, Mathias, Jachs, Mathias, Simbrunner, Benedikt, Bauer, David Josef Maria, Eigenbauer, Ernst, Strassl, Robert, Breuer, Monika, Kimberger, Oliver, Laxar, Daniel, Lampichler, Katharina, Halilbasic, Emina, Stättermayer, Albert Friedrich, Ba‐Ssalamah, Ahmed, Mandorfer, Mattias, Scheiner, Bernhard, Reiberger, Thomas, Trauner, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347407/
https://www.ncbi.nlm.nih.gov/pubmed/35596929
http://dx.doi.org/10.1002/hep.32582

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347407/
https://www.ncbi.nlm.nih.gov/pubmed/35596929
http://dx.doi.org/10.1002/hep.32582

Ejemplares similares